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Osteogenesis imperfecta (OI), or brittle bone disease, is a debilitating genetic 
disorder of connective tissue which is characterized by reduced skeletal mass and 
bone fragility. OI results from mutations in genes encoding for type I collagen. Since 
collagen is the major structural protein in bone, ligaments, tendons, skin, sclera and 
dentin, clinical manifestations of OI include fragile bones with skeletal deformity, 
blue sclerae, hearing loss, and opalescent teeth. 
The orthopedic manifestations of OI are diverse. Most OI patients present with long 
bone fractures, joint contractures, foot deformities and bowing of long bones. 
Successful treatment of this condition is potentially challenging and requires a 
multidisciplinary approach. Surgical intervention is cumbersome because of growing 
bone, poor bone quality and soft tissue contractures. Advances in the medical 
management of OI have shown promising increases in bone mineral density and 
decreases in fracture incidence.  
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Osteogenesis imperfecta (OI), or brittle bone disease, is a debilitating genetic 
disorder of connective tissue which is characterized by reduced skeletal mass and 
bone fragility.1 In contrast to osteomalacia, patients do not have disturbances in 
serum calcium and vitamin D levels. OI results from mutations in genes encoding for 
type 1 collagen which leads to formation of defective collagen. Since collagen is the 
major structural protein in bone, ligaments, tendons, skin, sclera and dentin, clinical 
manifestations of OI include fragile bones with skeletal deformity, blue sclerae, 
hearing loss, and opalescent teeth (dentinogenesis imperfecta).
2 
Less severe 
manifestations of OI include generalized ligamentous laxity, hernias, bruising 
tendency, and excessive sweating. 
Orthopedic manifestations of OI are diverse. Most patients with OI present with long 
bone fractures, joint contractures, foot deformities and bowing of long bones. They 
may have repetitive fractures which heal normally,
3
 although Cheung and Ramirez 
have reported hypertrophic callus formation and delayed healing in some patients.
4-
5
 The aim of this thesis is to review the epidemiology, genetics, classification, clinical 





Epidemiology and genetics 
OI has a prevalence of 1 in 15,000 children with wide variations in its phenotype.
6
 It 
is caused by mutation of either of the two chains that form type 1 collagen, the 
major structural protein of the extracellular matrix of bone, skin and tendons.
7-8
 The 
family of collagens is large and multivariable, each with their own different genes, 
structure and tissue distribution, and all with repetitive lengths. A collagen type 1 
molecule consists of three polypeptide chains (two alpha 1 and one alpha 2 chains) 
that intertwine via a glycine residue at every third position, forming a triple-helical 
heteropolymer. Type 1 is the major fibrillar collagen, molecules of which cross-link to 
form fibrils and fibres of considerable length.
9-10 Most cases of OI are caused by an 
autosomal dominant genetic mutation, and in about 90% this involves one or two of 
the genes that encode the α-chains of collagen type 1 (COL1A1 and COL1A2). These 
genes are located on chromosomes 17 and 7.
11-12




a. ‘Excluded’ type results in exclusion of the product of the mutant allele from 
the mature collagen molecule (non-deforming OI)  
b. ‘Included’ type that permits the incorporation of a structurally abnormal 
chain (deforming OI) 
 
Classification systems of Osteogenesis imperfecta 
In 1906, Looser classified OI into two forms, congenita or tarda, depending on the 
severity of presentation.
14
 Infants with OI congenita have multiple fractures in utero, 
whereas in individuals with OI tarda, fractures often occur shortly after birth or later. 
8 
 
Seedorf further subclassified OI tarda into two types: tarda gravis, in which the first 
fracture occurs in the first year of life, and tarda levis, in which the first fracture 
occurs after the first year of life,
15
 although this classification has since been 
superseded. Hanscom and Winter proposed a classification system (1992) based on 
the dynamic nature of eight radiographic changes (Table I).
16
  
i. Appearance of the diaphyseal cortex 
ii. Degree of tapering of the long bones 
iii. Platyspondylosis and biconcave vertebrae 
iv. Time of closure of the distal femoral and proximal tibial epiphyses 
v. Presence of chest wall deformity 
vi. Trefoil-shaped pelvis and protrusio acetabuli 
vii. Cystic changes in the epiphysis and metaphysis at the knee 




The most widely used OI classification system is proposed by Sillence et al.(1979), 
with types 1–4 based on clinical and radiological findings of skeletal deformities 
combined with genetic data.
17
 Recently a new group of patients has been identified 







Type 1 OI 
A non-deforming type, patients are of normal or low-normal height and they usually 
do not have limb deformities. The clinical hallmark of type 1 OI is bony fragility and 
often multiple fractures during childhood. Fractures become less common after 
puberty. Blue sclerae are present at birth. Kuurila and Imani in several studies have 
shown that around fifty percent of these patients develop presenile deafness which 
usually develops in the third decade of life and therefore is not observed in 
children.21, 22, 23 Fracture patterns include spiral and transverse fractures of long 
bones, particularly in the lower extremity. Avulsion-type fractures, such as olecranon 
and patellar fractures are common and are related to the decreased tensile strength 
of the bone because of low collagen content.
24
 Type 1 OI does not affect longevity 
but influences morbidity due to recurrent fractures and complications as malunion 
and subsequent angular deformities of long bones. 
 
Type 2 OI 
A lethal type and the most severe form of OI. Infants with type 2 OI die at or shortly 
after birth. They are born with crumpled femora and ribs which are accompanied by 
severe kyphoscoliosis and pulmonary hypoplasia, which usually leads to death. 
Narrow thoraces, short and deformed extremities with multiple fractures, and a 
typical frog-like position are the main features of this type. Central nervous system 
malformations and hemorrhages are common due to the markedly abnormal 
collagen. Survival beyond one year is very rare.
25 
 
Type 3 OI 
Type 3 OI accounts for approximately 20% of all patients with OI. This is the most 
severe of the types that survive. These patients have relatively large skulls but 
under-developed facial bones, leading to a characteristic triangular appearance of 
the face. The sclerae are usually pale blue at birth, but become normal in color by 
puberty. Patients are short in stature, with severe limb deformities including bowing 
of long bones and coxa vara. 
10 
 
Glorieux et al. have demonstrated that the characteristic popcorn appearance of the 
epiphysis and metaphysis which occurs in early childhood is caused by distortion of 
the growth plate, with zones of partially calcified cartilage and broadening of the 
epiphysis (Figure 1). These patients have poor muscle strength and muscular 
balance, and many use wheelchairs for mobility, or require walking aids.
26
 Widmann 
has described the relationship of spinal deformities and pulmonary compromise in 
patients with type 3 OI during anaesthetic interventions.
27 Lumbar vertebral pedicles 
are elongated, leading to spondylolisthesis at the lumbosacral junctions.
28
 The 
vertebrae are wedged and may assume a codfish-like biconcave morphology. Basilar 
invagination of the skull due to odontoid peg fracture and subsequent instability can 
present with headache, lower cranial nerve palsy, dysphagia, limb hyperreflexia, 




Type 4 OI 
Patients with type 4 OI have a relatively moderate clinical presentation. Most have 
short stature with bowing of long bones and vertebral fractures.  Inspite of multiple 
fractures in childhood with subsequent deformities, most patients are ambulatory. 
There is a wide age range for the first fracture and number of subsequent fractures 
in these patients. Dentinogenesis imperfecta may or may not be present in these 
patients. The sclerae are typically white.
30-31 
 
Type 5 OI 
OI Type 5 is moderate in severity. It is similar to type 4 in terms of frequency of 
fractures and the degree of skeletal deformity. The most characteristic feature of 
this type is large, hypertrophic callus formation in the long bones at fracture sites 
and  surgical procedure sites. Calcification of the interosseous membrane between 
the radius and ulna restricts forearm rotation and may cause dislocation of the radial 
head.31 Women with OI Type 5 anticipating pregnancy should be screened for 
hypertrophic callus in the iliac bone as it can act as an obstacle for passage of fetus 




Type 6 OI 
OI type 6 is extremely rare. It is moderate in severity and similar in appearance and 
symptoms to OI type 6. This type is distinguished by a characteristic mineralization 
defect seen in biopsied bone. The mode of inheritance is probably recessive, but it 
has not yet been identified.31 
 
Type 7 OI 
Type 7 resembles OI type 4 in many aspects of appearance and symptoms. Some 
cases resemble OI type 2, except that infants have white sclerae, small heads and 
round faces. Short humeri and femora are common, as is short stature. Coxa vara 
and trefoil pelvis are seen. OI type 7 results from recessive inheritance of a mutation 
in the cartilage-associated protein gene (CRTAP).30-31 Partial (10%) expression of 
CRTAP leads to moderate bone dysplasia. Total absence of CRTAP has been lethal in 
all identified cases.30 
 
Type 8 OI 
Cases of OI type 8 are similar to OI types 2 or 3 in appearance and symptoms except 
for white sclerae. OI type 8 is characterized by severe growth deficiency and extreme 
under-mineralization of the skeleton. It is caused by absence or severe deficiency of 
prolyl 3-hydroxylase activity due to mutations in the LEPRE1 (prolyl 3-hydroxylase 1) 
gene.30-31 
Differential diagnosis 
The differential diagnosis for suspected OI depends on the severity of the condition 
and on the age of presentation. The condition can manifest in a variety of ways, and 




Ramachandran differentiates OI according to age of presentation.
33
 Conditions 
which should be suspected in the prenatal/neonatal stage include chondrodysplasia 
punctata, chondroectodermal dysplasia, Jeune dystrophy hypophosphatasia and 
non-accidental injuries. These conditions share some similarities to osteogenesis 
12 
 
imperfecta. Patients with hypophosphatasia present with blue sclerae, fractures, and 
wide fontanelles. Hypophosphatasia is characterized by low serum alkaline 
phosphatase levels and, in the severe recessive form, skin dimples overlying Bowdler 
spurs located symmetrically on the midshaft of the fibula, ulna, and radius. 
During preschool years conditions such as pyknodystosis, osteochondromatosis, and 
Hajdu-Cheney syndrome have to be considered. During adolescence, Maffucci 
syndrome mimics OI. Other conditions which should be differentiated are rickets, 
osteopetrosis, Bruck’s syndrome, and congenital syphilis. 
Child abuse resembling OI  
The distinction between mild OI and non-accidental injury is sometimes very 
difficult, especially in early infancy. Mild OI without family history appears similar to 
non-accidental injury. However it must be kept in mind that the two conditions can 
also coexist. According to Glorieux, “Pediatricians, orthopedists, emergency room 
physicians, and others who see children with fractures need to consider OI as a 





Management of OI 
The goals of the treatment in OI are to decrease pain, prevent fractures and improve 
mobility. Treatment depends on the severity of the disease and on the age of the 
patient. A treatment strategy incorporates a multidisciplinary team approach which 
includes the pediatrician, geneticist, orthopedic surgeon, physiotherapist, 




Mainstay of treatment 
As per the National Institute of Health’s guide to OI for pediatricians and family 
physicians, the treatment strategies are centered over behavioral and lifestyle 
modifications, rehabilitation to improve muscle strength, orthopedic surgery for 
13 
 




Behavioral and lifestyle modifications 
Infants with OI are prone to fracture with trivial trauma, thus one of the most 
important aspects of treatment is gentle handling from infancy. As these patients 
grow, proper techniques for lifting, sitting and standing must be  employed. 
It is of utmost importance to modify the home and school environment such as 
keeping the floor free of obstacles that could cause an accident. Strenuous activities 





Physiotherapy and rehabilitation 
Physiotherapy, rehabilitation, and occupational therapy are important elements of 
the multidisciplinary approach to the management of OI. Physiotherapy helps to 
maintain muscle tone and optimal function. Early rather than late intervention is 
advocated, as immobilization after fracture reduces lean muscle mass, which leads 
to a decline in bone mineral density.
34,36
 Psychological and social support, 
involvement of parents and school teachers is imperative for successful 
management.  
 
Medical management, bisphosphonate therapy 
Medical treatment of OI with bisphosphonates is not curative, but successfully 
controls symptoms. Nitrogen and non-nitrogen containing classes of 
bisphosphonates exist (Table III). Alendronate has a proven beneficial effect, 





Bisphosphonates are synthetic analogues of inorganic pyrophosphate that inhibit 
osteoclastic bone resorption. The primary effect is the inhibition of protein 





 Oral bisphosphonates have a very poor rate of gastrointestinal 
absorption.
39
 Of the absorbed bisphosphonate, 20% to 80% is incorporated into the 
skeleton. Bisphosphonates are then slowly released into the system, with a half-life 
of 1.5 to 10 years. The earliest response to treatment usually occurs in 1 to 6 weeks 
after the initiation of therapy. Studies have shown that there is marked reduction in 
chronic bone pain, improvement in ambulation, decrease in incidence of fractures 
and improvement in bone mineral density.
40
  
Biochemical markers, namely the serum concentration of calcium and phosphate are 
used for treatment monitoring. Serum calcium and phosphate concentrations 
decrease for 2 to 4 weeks, and that of alkaline phosphatase decreases for 3 to 4 
months. Both oral and intravenous bisphosphonates are equally safe for children 
with OI. The duration of therapy should be limited to approximately two years. 
Therapy leads to suppression of bone metabolism for almost two years even after 
cessation of therapy,
41
 and bone mass continues to increase after treatment stops. 
 
Because bisphosphonates interfere with bone formation and resorption, some 
authors believe that it may change the course of fracture healing, and in some cases 
healing of osteotomies.
42-43
 Thus it is advised to temporarily stop bisphosphonates 
during periods of fracture healing and deformity corrections. Osteonecrosis of the 
jaw is a rare condition which may occur with bisphosphonate therapy although its 
exact incidence is unknown. 
 
Surgical management 
The main aim of surgical intervention in patients with OI is to prevent and correct 
long-bone deformities that impair function. The spectrum of  surgery ranges from 
minor soft tissue procedures to more complicated reconstructive procedures.
44-46
 
Deformities of the  femur and tibia undergo reconstruction more frequently than the 
humerus,





Long bone fractures 
Patients with OI may present with fractures at any age. Fractures in a new-born may 
be splinted with padded tongue depressors, aluminium splints, or plaster splints. 
Immobilisation should last for a short period, usually a week or two. 
 
Fractures in children older than two years should be treated by means of reduction 
and casting, percutaneous pinning, or internal fixation. Rigid implants such as pins 
and plates or screws are not recommended, as stiff devices create stress risers 




The classical method oflong bone fixation in OI is intramedullary rods with or 
without osteotomies (Figure 2). Various types of intramedullary rods are available to 
address issues related to surgery, bone size, and the prospect for growth.
48
 Two 
major categories of intramedullary rods are telescopic and non-telescopic. 
Telescopic rods expand during growth and thus theoretically obviate revision 
surgery, and include Dubow–Bailey rods, Fassier–Duval rods, and Sheffield rods. 




Non-telescopic rods do not expand and require replacement once the child’s bone 
lengthens and begins to bow. These rods are cheap and redily available and easy to 
use. Non-telescopic rods may be the only option for children with very short, thin 
bones. The most common non-telescopic rods in use are Kirschner wires, Rush rods, 
Williams rods and elastic rods. In young adult patients, external fixation with an 
Ilizarov circular fixator and osteotomy can be used to correct long-bone deformity.
50  
 
Fractures and osteotomies in patients with OI usually heal well. However, non union 
can occur in some patients. The incidence of non-union in OI has been extensively 
reviewed. Gamble and associates reported 12 nonunions in 10 patients which 







Perioperative and surgical technique considerations 
Care should be taken during intubation of a potentially fragile cervical spine and 
increased incidence of cranial settling.
52
 Occurrence of malignant hyperthermia has 
been documented in the literature but the relationship appears weak.
53
 Due to rigid 
and low elasticity of the skin and poor vascularity,  the rate of infection and skin 
breakdown is high in patients with OI. Care should be taken whilst transferring 
patients to avoid fracture. 
Flat, thin cortices provide a technical challenge for insertion of intramedullary rods 
to long bone fractures, and rod cut-out is a recognized complication. Severe 
deformities posees a challenge in acute correction due to risk of neurovascular 




Sclerostin, an osteoblast inhibitor, has been studied in clinical trials. Antibodies to 
sclerostin are used for treatment for osteoporosis with a goal to increase bone 
density. Its antibody appeared to be effective in a mouse model of moderately 
severe OI.
54-55
 It has been postulated that TGFb is secreted by osteoblasts which 
resorbs bone. Transforming growth factor activity is found to be excessive in OI. 




 or mesenchymal stem cell transplantation
58 
have also been 
investigated for use in OI, but significant risks have been identified. Gene therapy 









The Aim: The purpose of this collective review was to analyse the diversity of 
orthopedic manifestations of OI through a systematic review of the literature. 
Search Strategy: An electronic search was performed that included Google Scholar, 
PubMed, and Elsevier. The search was conducted according to ‘preferred reporting 
items for systematic reviews and meta-analyses’ (PRISMA) guidelines (Figure 3). Data 
extraction and analysis:  A computer based search was conducted and the keywords 
included were ‘osteogenesis imperfecta’ and ‘orthopedic manifestations’. The period 
of review was from 1970 to 2013 without language restrictions. The following 
articles were included: randomized controlled trials; review articles; meta-analysis; 
and case reports which described the classification, clinical and radiological 





The orthopedic manifestations of OI have been summarized in Table IV. 
 
Spine 
The pathogenesis of spinal deformities in OI is complex and is attributed to 
combination of weak bone and ligamentous laxity. Vertebral growth plates are prone 
to microfractures, resulting in growth inhibition and vertebral abnormalities. 
Intervertebral discs are often stronger than vertebral body bone.
60-62
 The resultant 
compression fractures give the vertebrae a codfish appearance (Figure 4). 
 
Spinal fractures 
In patients with OI vertebral collapse, compression fractures are commonly seen, 
and the incidence increases with age. Norimatsu relates it to upright posture and the 




Craniocervical junction and cervical abnormalities 
The upper cervical spine is rarely affected in OI. Though patients do not develop 
acute symptoms, one of the most serious abnormalities that can occur is basilar 
invagination. Pozo et al. reviewed three patients with basilar invagination and 
postulated that weak bone at the craniocervical junction and a relatively large head 
both contribute to the development of the condition.
64
 Basilar invagination along 
with medial migration of the occipital condyles cause stenosis and interfere with 
cerebrospinal fluid dynamics. This interference causes internal hydrocephalus and 
subsequent compression of the cerebellum, brain stem, and upper cervical cord. 
Clinically this leads to various cranial nerve abnormalities, long-tract signs, and 
respiratory depression. 
 
Hyperextension at the cervicothoracic junction has been described as a rare case. 
This deformity is postulated to be associated with a C7 vertebral body microfracture 
19 
 
with posterior wedging and compensatory forward bending moment in order to 




Sagittal and coronal deformities of the spine in OI 
Multiple compression fractures of the spine and reduction in vertebral height lead to 
increased thoracic kyphosis or a diminished lumbar lordosis. These progress to global 
sagittal trunk imbalance.
66
 With increasing age, the spinal deformity worsens and 
hence the complications such as back pain, respiratory distress and nerve root 
compression may develop. The natural course of the spinal deformity is usually 
unpredictable.
62 
Ivo et al. stated that bracing alone fails to control the curvature and 
often early spine fusion with or without instrumentation is considered to be a viable 
option.67 
 
Spondylolysis & spondyloptosis or spondylolisthesis 
Due to the bone fragility and multiple compression fractures of the vertebrae, an 
increased incidence of spondylolysis and spondylolisthesis is seen. Ivo et al. 67 
postulated that hyperlordosis of the lumbar spine was caused by elongation of the 
lumbar pedicles and consecutive spondylolisthesis (Figure 6). Despite such 
deformities, neurological deficits do not usually occur. Absence of neurology in these 
patients is attributed to associated dural ectasia.  
 
Upper and lower extremities 
Lower limbs 
The lower limb bones are more frequently fractured, and fracture patterns depend 
on injury mechanism, severity of bone fragility, and the presence of pre-existing 
deformity acting as a stress riser. Any fracture pattern may be seen and no particular 






Fractures heal at a normal rate in OI and non-union occurs relatively rarely.
68-69
 
Fracture callus is typically wispy, but on rare occasions it may be large and 
hyperplastic (Figure 7) resembling osteogenic sarcoma on radiographs.  
 
In the lower extremity, the femur is the most commonly fractured bone. The 
intertrochanteric and subtrochanteric regions are the most common sites leading to 
coxa vara and trochanteric overgrowth (Figure 8). 
70
 Multiple transverse fractures of 
long bones, combined with muscle contraction across the weakened diaphysis, leads 
to long bone bowing. Typically, anterolateral bowing of the femur and anterior or 
anteromedial bowing of the tibia (sabre shin deformity) may occur. Clinically the 
shaft of long bones is flattened mediolaterally and often rotated in addition to the 
curvature. 
Multiple long bone deformities of the limbs are caused by angulations and overriding 
of healed fractures, growth disturbance at the physes, and marked kyphoscoliosis 
results in short stature. Pes valgus and club foot deformities are commonly seen. 
One case of associated developmental dysplasia of the hip has been described.
71
 





Upper limb fractures are relatively rare in comparison to those of lower limbs. 
Multiple transverse fractures of the humerus lead to anterolateral bowing. In 
patients with OI type 5, Sillence has shown that calcification of the interosseous 
membrane between the radius and ulna restricts forearm rotation. Angular 
deformity and repetitive fractures with exuberant callus formation leads to radial 
head dislocation (Figure 9). Angulation is generally greater in the upper part of both 
bones of the forearm.  
Bowing and curvatures of the upper limbs are attributed to weight bearing through 
the upper limbs while sitting in a tripod position in bed for prolonged periods. 




70 A fracture that occurs commonly in mildly affected patients with 




The characteristic appearance of the pelvis in OI is referred to as "wine glass pelvis". 
Due to soft bone, acetabular protrusio develops. There is usually progressive 
restriction of hip movements with protrusio. Wenger reported a case of protrusio 




Increased capillary fragility caused by the underlying collagen defect is associated 
with the tendency to bruise easily in OI. Evensen has postulated decreased platelet 
retention and reduced factor VIII in patients with OI.
75 Hansen studied the 
mechanical properties of the skin and found that their skin is much stiffer and less 
elastic than normal individuals.
76 
Core muscle strength is much reduced,
77-78
 and 
joint hyperlaxity is common, especially in affected females, which can lead to 
dislocation of hips and the radial heads. 
 
Skull 
One of the pathognomonic radiologic manifestations of OI occurs in the skull. The 
occiput becomes prominent (“Darth Vader” appearance) or a flattening of the 
cranial vault with transverse in folding of the cranial base (“Tam O’Shanter skull”), 
(Figure 10). These deformities are however very rare.
79
 Patients with OI often have 
triangular faces. 
 
In many instances, radiographs reveal multiple wormian bones, often ten or more,
80
 
that lend a “mosaic” or “paving” appearance to the cranial vault (Figure 11). 
Wormian bones are a subset of the small intrasutural bones that lie between the 
22 
 
cranial sutures formed by the bones of the skull vault. The term wormian is reserved 
for abnormal intrasutural bones that are typically found around the lambdoid suture. 
Summary 
Osteogenesis imperfecta is a group of genetic disorders with high musculoskeletal 
morbidity. Management of children affected with severe forms of OI may have a 
debilitating psychosocial impact on their family members. Though fractures heal, the 
deformities of long bones, soft tissue contractures and soft bones compound 
management strategies. A multidisciplinary approach in the management of OI is 
essential to achieve long term goals. Newer therapies like bisphosphonates, 
sclerostin, transformin growth factors and gene therapy have shown promising 
results. 
Surgery in OI patients requires considerable pre-operative planning with regards to 
anaesthetic issues, bone quality and implant / bone compatibility. This review 
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Figures and figure legends 
 
Figure 1. Bilateral lower limb radiograph shows “popcorn” appearance of the 
epiphyses. Severe OI causes distortion of the growth plates, with zones of partially 
calcified cartilage and broadening of the epiphyses. 
 
Figure 2. Anteroposterior and lateral radiographs of left tibia and fibula 
demonstrating segmentation of the tibia with an intramedullary rod in situ 
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Figure 4. Lateral radiograph of thoracolumbar  spine demonstrating cod 
fish vertebra appearance (biconcave compression fracture s) 
 
   
Figure 5. Lateral radiograph of the cervical spine showing the hyperextension 





Figure 6. Lateral radiograph of upper lumbar spine, showing spondylolisthesis caused 
by extreme elongation of lumbar pedicles.  
 
 





Figure 8. Anteroposterior radiograph of the pelvis and both femurs, demonstrating 
fractures of the right femoral neck, left femur subtrochanteric region and right 
femur diaphysis with subsequent coxa vara deformity, trochanteric overgrowth and 




Figure 9. Malunited humerus fracture with cubitus valgus and radial head dislocation 
 
  
Figure 10. Darth Vader and Tam O’Shanter images, to which skull deformities in OI 

























A + - - - - - - 
B + + - - - - 
C + + + - - - 
D + + +- + + - 
E + + + + + - 
F + + - - + + 
 
 
Table II. Sillence classification expanded with OI types 5-8 as proposed by Rauch 
(2004) & Cabral (2007) 
Sillence 
type 




1 Mild non-deforming COL1A1/2 AD 
2 Perinatal lethal COL1A1/2 AD 
3 Severely deforming COL1A1/2 AD 
4 Moderately deforming COL1A1/2 AD 
5 Moderately deforming Unknown AD 
6 Moderately or severely deforming Unknown AR 
7 Moderately deforming CRTAP AR 
8 Severely deforming to perinatal lethal  LEPRE1 AR 




Table III. Bisphosphonates used for OI 
Drug name Class Generation Administration 
Etidronate Non-nitrogen containing 1st  Oral  
Clodronate Non-nitrogen containing 1st  Oral or IV 
Pamidronate Nitrogen containing 2nd Intravenous 
Ibandronate Nitrogen containing 2nd Oral or IV 
Alendronate Nitrogen containing 2nd Oral 
Risedronate Nitrogen containing 3rd Oral 
Zolendronate Nitrogen containing 3rd Intravenous 
 
 




General Short stature 
Skull Broad forehead; flattened posterior cranium; overhanging occiput; 
bulging calvaria (wormian bones); triangular face shape 
Long bones Anterior bowing of humerus, tibia and fibula; lateral bowing of femur, 
radius and ulna; dislocation of radial head; bone fragility characterized 
by multiple pathologic fractures resulting in bone deformity 
Spine Thoracic kyphoscoliosis; elongation of lumbar and cervical pedicles; 
vertebral body compression fractures; codfish appearance 
Pelvis Trefoil–shaped pelvis with protrusio acetabuli; coxa vara; wine glass 
appearance of pelvis 
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Introduction
Osteogenesis imperfecta (OI) results from mutations in
genes encoding for type I collagen. Collagen is the major
structural protein in bone, ligaments, tendons, skin, sclera
and dentin.1 
Type I collagen is also an integral component of several
extraskeletal tissues leading to dentinogenesis imperfecta,
blue sclerae, hearing impairment and hyperlaxity of the skin
and ligaments.7
Mutant expression produces non-functional collagen
(severe OI) or insufficient quantities of collagen (mild OI).1 
The pathogenesis of spinal deformities in OI is still
unknown, but is thought to be caused primarily by a combi-
nation of vertebral micro fractures due to the fragility of the
bones and injury to the vertebral growth plate. Ligamentous
laxity, limb-length discrepancy, pelvic obliquity, and abnor-
malities of the discs are secondary factors.4-6 
In severe forms of OI, progression of multiple compression
fractures of the spine and vertebral height shortening may
be responsible for a global sagittal trunk imbalance.3,4,9,17
Studies have indicated that the incidence increases with
age. This may be due to the upright posture and the effect of
axial loading on the weak spinal column.4,5,8,9 It has been
found4,6,8,10 that the intervertebral discs are stronger than the
bone of the vertebral bodies and that compression fractures
give the vertebrae a codfish appearance.
We describe a case of hyperextension of the CD junction.
The case report
A three-year-old child was referred with OI with hyperex-
tension at the CD junction.
Perinatal history revealed normal vaginal delivery but
delayed developmental milestones. The child was not able
to lift her head until the age of three months. The child had
sustained multiple long bone fractures following trivial trau-
ma, which included bilateral femora and right humerus. The
child was on regular follow-up with endocrinologists, and
was treated with zoledronic acid.
On general examination the child had macrocephaly, blue
sclera and poor dentition as well as kyphotic deformity of
the cervical and thoracic spine. She was not able to stand or
crawl, but could sit with support.
The child was spastic (Ashworth 2)15 with altered sensory
level from T2 and associated bowel and bladder involve-
ment. 
Further examination revealed bilateral anterolateral bow-
ing of femora with associated limb length discrepancy on the
left lower limb.
CT scan revealed CD junction hyperextension with elon-
gation of the pedicles and attenuation of the posterior ele-
ments (Figure 1). There was no evidence of fractures.
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The pathogenesis of spinal deformities in OI is thought to be caused
primarily by a combination of vertebral micro fractures due to the
fragility of the bones and injury to the vertebral growth plate
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Further images showed scalloping and wedging at the
posterior vertebral body at the level of C7 with associated
hyperextension.
MRI scans showed widening of the canal at the same level
(Figure 2).
Discussion
Although OI is a well-known skeletal disease, there have
been only a few reports of spondylolisthesis in the lumbar
spine.7 Familiarity with the normal developmental anatomy
and radiographic features, along with knowledge of the
common manifestations of hereditary and systemic diseases,
are prerequisite to understanding the disorders that affect
the paediatric cervical spine.13
The transition of the ‘C’-shaped vertebral column to an ‘S’
shape occurs as a child starts to sit and stand with develop-
ment of cervical and lumbar lordosis respectively. The C-
spine essentially is free to rotate about the CD junction due
to the relative immobility of the trunk during head move-
ment. The C-spine thus acts as a cantilever beam with the
‘fixed end’ at the CD junction, the location of the highest
stresses. 
The spine depends upon a balance of forces during growth
and development. Pathologies affecting the bony or soft tis-
sue component around the spine could lead to deformity in
different planes. 
OI disrupts the musculoskeletal matrix resulting in change
in the morphology of vertebral bodies which may result in a
spinal deformity.
In our patient the hyperextension deformity might be asso-
ciated with a C7 vertebral micro fracture with posterior
wedging and compensatory forward bending moment in
order to withstand the weight of the macro-cephalic skull.
Furthermore delayed milestones with the inability to lift the
head might have led to persistent kyphosis of the cervical
spine in order to maintain the mechanical axis with the tho-
racic spine.
As shown by Basu et al14 elongation of pedicles with result-
ant rapid progression of spondylolisthesis leads to persistent
hyperlordosis of the spine above. 
Pathologies around the CD junction give rise to a kyphotic
deformity and are associated with neurological deficits
because of the mechanical effects and smaller size of the
canal and tenuous blood supply to the lower cervical cord.11
Ronald et al reported three patients with OI showing 
angular hyperlordosis caused by elongation of the lumbar
pedicles and consecutive spondylolisthesis.7 Our patient had
elongation of the pedicles and crowding of posterior 
elements with associated spondylolisthesis and resultant CD
junction hyperextension.
During childhood with increased mechanical loads, 
pedicle elongation and hyperlordosis shows a rapid 
progression.3 This fits the hypothesis that osteopaenia 
causes increased micro damage in OI bones, resulting in
increased bone remodelling and, with raised mechanical
strains, progressive deformations.
Basu et al14 reported successful treatment of patients 
suffering from spondylolisthesis in OI due to lumbar pedicle
elongation with interbody fusion without instrument;
whereas Ronald Ivo et al7 treated three patients with 
spondylolisthesis due to lumbar pedicle elongation with
laminectomy and posterolateral fusion.
Figure 1. Sagittal X-ray of Cx spine showing the 
hyperextension deformity at the CD junction Figure 2. MRI scans showing the widening of the canal
OI disrupts the musculoskeletal matrix resulting in change 
in the morphology of vertebral bodies which may result in a 
spinal deformity
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Our patient was treated with cervical traction for a period
of six weeks followed by posterior instrumentation. 
Surgery was performed in two stages. Initially the child
was kept on cervical traction for a period of six weeks. Pin
site care was done on a regular basis and no infection was
encountered during the period. 
Due to the soft and fragile bony architecture which was
encountered during surgery, posterior decompression and
instrumentation with pedicle screws and rods was 
performed (Figure 3).
She has now been followed up for 12 months after her sur-
gery. At the latest follow-up her neurology has improved to
Frankel D grade.16
Conclusion
Although there are case reports on the management of
severe kyphotic deformities of the thoracolumbar spine in
OI4,6,8,12 there are no reports addressing the pathology around
the CD junction with hyperextension deformity. We 
have presented a unique case of OI with hyperextension
deformity at the CD junction.
The content of this article is the sole work of the authors. No bene-
fits in any form have been or will be received from a commercial
party related directly or indirectly to the subject of this article.
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Title of study: 
Orthopaedic manifestations of Osteogenesis Imperfecta (OI) – A collective review 
 
Aim of the study: 
This study will highlight a critical overview of the current literature with respect to 
'Orthopaedic manifestations of Osteogenesis Imperfecta'. The study will focus on delineating 
spectrum of orthopaedic manifestations. The study will also deal with epidemiology, pathology, 
treatment and its complications. 
 
Specific objectives 
 Study the epidemiology of OI 
 The classification system of OI 
 Describe the pathology and pathogenesis of OI 
 Identify the regional affectation of OI 
 Establish the role of Orthopaedic surgeon in management of OI 
 
Background 
Osteogenesis Imperfecta is one of the commonest of the genetic disorders of bone; with an 
estimated incidence of 1 in 20,000. The condition is hereditary and is characterised by fragile 
bones, spinal deformity, blue sclera, deafness, laxity of joints and a tendency towards 
improvements with age.  
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OI results from mutations in genes encoding for type I collagen. The Sillence classification has 
been used to classify OI according to its clinical severity.  
The clinical features vary considerably, according to the severity of the condition. The most 
striking abnormality is the propensity to fracture, generally after minor trauma and often 
without much pain or swelling. 
In most cases the clinical and radiological features are so distinctive that the diagnosis is not in 
doubt. However, mistakes have been made and rare disorders causing multiple fractures may 
have to be excluded by laboratory tests. In hypophosphatasia, for example, the serum alkaline 
phosphatase level is very low. 
It becomes imperative in reviewing the topic to understand the pathophysiology, clinical 
variants and regions of skeletal involvement in order to address the pathology. 
 
  Literature  
Osteogenesis Imperfecta is a rare genetic disorder that causes increased bone fragility. OI results 
from mutations in genes encoding for type I collagen. Collagen is the major structural protein in 
bone, ligaments, tendons, skin, sclera, and dentin. 1 The main clinical characteristics is increased 
bone fragility, which varies widely in severity, ranging from intrauterine fractures and perinatal 
death to mild forms that remain asymptomatic until late in adult life.2,3 
OI is classified into various forms depending upon on age of presentation, genetic abnormality and 
clinical severity. The Sillence 4 classification has been used to classify OI according to its clinical 
severity into four different types. Clinical severity varies widely depending on its phenotypes and 
currently eight types are identified. 5, 6 
Orthopedic manifestations range from angular bone deformity and curvature, recurrent fractures, 
ossification of interosseous membrane of the forearm, radial head dislocations, ankylosis of hips, 
pelvic deformity, spondylolisthesis of lumbar vertebrae and deformities of spine altering the sagittal 
balance of the spine. 
Treatment of OI depends on the severity of the disease and on the age of the patient; in any case a 
treatment strategy should provide the maximum of long term function and autonomy.7, 8, 9 
Lifelong multidisciplinary management is imperative in order to address different aspects of the 
disease. Intravenous bisphosphonate therapy in childhood is the most extensively studied treatment 
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and has been proved beneficial. 10 Prevention of vitamin D and calcium deficiency is essential 
throughout life. Various orthopedic and surgical techniques are available for reducing fractures and 
correcting the deformities. Pain is common and should be addressed effectively. 
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A collective review of the literature via the relevant search engines and search terms will be 
undertaken. 
 
Search engines and electronic databases: 
 UKZN Primo search 
 Biomed central 
 PubMed 
 Science direct 
 Cochrane Library 
 EBSCO host 
 Google scholar 
 
AN experienced medical librarian will be consulted to improve the general approaches for 
conducting a comprehensive search of the above databases. 
 
Relevant search terms will include the following keywords: 
 Osteogenesis  
 Imperfecta 
 Orthopaedic manifestations 
 Deformities 
 Silience  
 Brittle bone 
 
The inclusion criteria: 
 Human subjects. 
 No age predilection 
 English language text 
 Period – year 1970 to the present 
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 Studies from both developed and developing countries 
 
 
Data collection methods: 
Academic books, journals and various publications on the subject will be used to collect the relevant 
data. Information will be gathered from studies that include randomized controlled trials, review 
articles, case reports and systemic reviews. 
Literature published from late 70’s will be used for this review since most of the initial works were 
done around that period. 
Studies meeting the obvious inclusion criteria will be assessed for its inclusion. Microsoft word, excel 
will be used to summarise and categorise the main results. 
 
Data analysis: 
Studies will be evaluated through content analysis, as meta-analyses will not be feasible due to the 
vast variety of study designs and variables. 
The study will focus only on qualitative research design. 
 
The study will be analysed by comparing and contrasting content related to 
 Epidemiology 
 Pathology 
 Clinical manifestations 
 Management / treatment strategies 
 Complications 
 Outcome measurements 
The data will be categorised and crossed checked against the inclusion and exclusion criteria. The 
findings will be evaluated and conclusions will be drawn. Clinical significance with regards to 
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Limitations to the study 
 The study will rely solely on databases, electronic sources for the literature search, conference 
proceedings as well as literature prior to the study period mentioned and the absence of two or 
more reviewers to independently collate and appraise the data. 
 
Ethical considerations  
This is not applicable as the study is a review of the literature and does not involve the participation 
of the patients, use of pharmaceutical products or any other treatment strategies. 
 
 
 
 


